Product image of Evusheld (Cilgavimab | Tixagevimab) supplied by GNH India

Evusheld

Active Ingredient:
Cilgavimab | Tixagevimab
Origin:
EU

Evusheld (Cilgavimab | Tixagevimab)

Evusheld is a combination of cilgavimab and tixagevimab, used for pre-exposure prophylaxis of COVID-19. This intramuscular injection is manufactured by AstraZeneca AB in the EU.

Manufacturer / TM Owner

Astrazeneca Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Evushel is designed to help prevent COVID-19 in individuals who may not respond adequately to vaccination. It contains two monoclonal antibodies, cilgavimab and tixagevimab, which work together to provide protection against the virus. This medication is typically administered as a preventive measure for those at high risk of exposure or severe infection.

Side Effects

  • Common effects of Evusheld may include reactions at the injection site, such as pain, swelling, or redness. Some individuals might experience general side effects like headache, fatigue, or muscle pain. These effects are usually mild and temporary.

Precautions & Warnings

  • Evusheld should be used under the guidance of a healthcare professional. It is important to inform your healthcare provider about any allergies or medical conditions before administration. Always follow the prescribed storage and handling instructions to maintain the medication's effectiveness.

Avoid Interactions

  • Evusheld may interact with other medications, particularly those that affect the immune system. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, avoid alcohol consumption around the time of administration to minimize the risk of side effects.

Frequently Asked Questions

Evusheld is used for pre-exposure prophylaxis of COVID-19 in individuals who may not respond adequately to vaccination.

Evusheld is administered as an intramuscular injection, typically in a clinical setting under the supervision of a healthcare professional.

Common side effects may include reactions at the injection site, headache, fatigue, and muscle pain.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Individuals with known allergies to cilgavimab or tixagevimab should avoid using Evusheld.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cilgavimab | Tixagevimab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT